4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001415889-25-002287
Chief Financial Officer bought 24,000 shares at $5.40 ($129,600)
- Chief Financial Officer acquired 12,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Young James Emmett Chief Financial Officer | 2025-01-27 | Grant or award | +12,500 | 21,726 | D | ||
| Young James Emmett Chief Financial Officer | 2025-01-27 | Purchase | +24,000 | $5.40 | $129,600 | 24,000 | I |
| Derivatives | |||||||
| Young James Emmett Chief Financial Officer | 2025-01-27 | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | D | ||
| Open-market purchases · 24,000 sh · avg $5.40 · $129,600 | |||||||
Loading xslF345X05/form4-01292025_110141.xml…